77 related articles for article (PubMed ID: 22791810)
1. Increased levels of the HER1 adaptor protein Rukl/CIN85 contribute to breast cancer malignancy.
Samoylenko A; Vynnytska-Myronovska B; Byts N; Kozlova N; Basaraba O; Pasichnyk G; Palyvoda K; Bobak Y; Barska M; Mayevska O; Rzhepetsky Y; Shuvayeva H; Lyzogubov V; Usenko V; Savran V; Volodko N; Buchman V; Kietzmann T; Drobot L
Carcinogenesis; 2012 Oct; 33(10):1976-84. PubMed ID: 22791810
[TBL] [Abstract][Full Text] [Related]
2. The adaptor protein Ruk/CIN85 activates plasminogen activator inhibitor-1 (PAI-1) expression via hypoxia-inducible factor-1alpha.
Samoylenko A; Dimova EY; Kozlova N; Drobot L; Kietzmann T
Thromb Haemost; 2010 May; 103(5):901-9. PubMed ID: 20216986
[TBL] [Abstract][Full Text] [Related]
3. Adaptor protein Ruk/CIN85 is associated with a subset of COPI-coated membranes of the Golgi complex.
Havrylov S; Ichioka F; Powell K; Borthwick EB; Baranska J; Maki M; Buchman VL
Traffic; 2008 May; 9(5):798-812. PubMed ID: 18266907
[TBL] [Abstract][Full Text] [Related]
4. Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma.
Mayevska O; Shuvayeva H; Igumentseva N; Havrylov S; Basaraba O; Bobak Y; Barska M; Volod'ko N; Baranska J; Buchman V; Drobot L
Exp Oncol; 2006 Dec; 28(4):275-81. PubMed ID: 17285110
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional regulation of NOX genes express ion in human breast adenocarcinoma MCF-7 cells is modulated by adaptor protein Ruk/CIN 85.
Bazalii AV; Horak IR; Pasi chn yk GV; Komisarenko SV; Drobot LB
Ukr Biochem J; 2016; 88(1):119-25. PubMed ID: 29227594
[TBL] [Abstract][Full Text] [Related]
6. Activation of c-Src/HER1/STAT5b and HER1/ERK1/2 signaling pathways and cell migration by hexachlorobenzene in MDA-MB-231 human breast cancer cell line.
Pontillo CA; García MA; Peña D; Cocca C; Chiappini F; Alvarez L; Kleiman de Pisarev D; Randi AS
Toxicol Sci; 2011 Apr; 120(2):284-96. PubMed ID: 21205633
[TBL] [Abstract][Full Text] [Related]
7. Intersectin 1 forms a complex with adaptor protein Ruk/CIN85 in vivo independently of epidermal growth factor stimulation.
Nikolaienko O; Skrypkina I; Tsyba L; Fedyshyn Y; Morderer D; Buchman V; de la Luna S; Drobot L; Rynditch A
Cell Signal; 2009 May; 21(5):753-9. PubMed ID: 19166927
[TBL] [Abstract][Full Text] [Related]
8. CIN85/RukL is a novel binding partner of nephrin and podocin and mediates slit diaphragm turnover in podocytes.
Tossidou I; Teng B; Drobot L; Meyer-Schwesinger C; Worthmann K; Haller H; Schiffer M
J Biol Chem; 2010 Aug; 285(33):25285-95. PubMed ID: 20457601
[TBL] [Abstract][Full Text] [Related]
9. Emerging roles of Ruk/CIN85 in vesicle-mediated transport, adhesion, migration and malignancy.
Havrylov S; Redowicz MJ; Buchman VL
Traffic; 2010 Jun; 11(6):721-31. PubMed ID: 20331533
[TBL] [Abstract][Full Text] [Related]
10. Multiple molecular forms of adaptor protein Ruk/CIN85 specifically associate with different subcellular compartments in human breast adenocarcinoma MCF-7 cells.
Vynnytska-Myronovska BO; Bobak YP; Pasichnyk GV; Igumentseva NI; Samoylenko AA; Drobot LB
Ukr Biochem J; 2014; 86(5):102-10. PubMed ID: 25816594
[TBL] [Abstract][Full Text] [Related]
11. ADAPTOR PROTEIN Ruk/CIN85REGULATES REDOX BALANCE IN 4T1MOUSE BREAST CANCER CELLS EXPOSED TO PLASMIN(OGEN).
Horak IR; Latyshko NV; Hudkova OO; Tokarchuk KO; Kishko TO; Yusova OI; Drobot LB; Tykhomyrov AA
Exp Oncol; 2022 May; 44(1):31-38. PubMed ID: 35548969
[TBL] [Abstract][Full Text] [Related]
12. Multiple domains of Ruk/CIN85/SETA/CD2BP3 are involved in interaction with p85alpha regulatory subunit of PI 3-kinase.
Borthwick EB; Korobko IV; Luke C; Drel VR; Fedyshyn YY; Ninkina N; Drobot LB; Buchman VL
J Mol Biol; 2004 Oct; 343(4):1135-46. PubMed ID: 15476827
[TBL] [Abstract][Full Text] [Related]
13. CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery.
Nam JM; Onodera Y; Mazaki Y; Miyoshi H; Hashimoto S; Sabe H
EMBO J; 2007 Feb; 26(3):647-56. PubMed ID: 17255943
[TBL] [Abstract][Full Text] [Related]
14. TRAIL/MEKK4/p38/HSP27/Akt survival network is biphasically modulated by the Src/CIN85/c-Cbl complex.
Kim J; Kang D; Sun BK; Kim JH; Song JJ
Cell Signal; 2013 Jan; 25(1):372-9. PubMed ID: 23085457
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor type-1 gene expression and induced migration in TGF-beta1-stimulated smooth muscle cells is pp60(c-src)/MEK-dependent.
Samarakoon R; Higgins CE; Higgins SP; Kutz SM; Higgins PJ
J Cell Physiol; 2005 Jul; 204(1):236-46. PubMed ID: 15622520
[TBL] [Abstract][Full Text] [Related]
16. Involvement of PI3K/Akt signaling pathway in hepatocyte growth factor-induced migration of uveal melanoma cells.
Ye M; Hu D; Tu L; Zhou X; Lu F; Wen B; Wu W; Lin Y; Zhou Z; Qu J
Invest Ophthalmol Vis Sci; 2008 Feb; 49(2):497-504. PubMed ID: 18234991
[TBL] [Abstract][Full Text] [Related]
17. Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification.
Tanizaki J; Okamoto I; Fumita S; Okamoto W; Nishio K; Nakagawa K
Oncogene; 2011 Sep; 30(39):4097-106. PubMed ID: 21499301
[TBL] [Abstract][Full Text] [Related]
18. ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis.
Tan M; Li P; Klos KS; Lu J; Lan KH; Nagata Y; Fang D; Jing T; Yu D
Cancer Res; 2005 Mar; 65(5):1858-67. PubMed ID: 15753384
[TBL] [Abstract][Full Text] [Related]
19. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
[TBL] [Abstract][Full Text] [Related]
20. Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homologue enriched in brain.
Yu J; Henske EP
Cancer Res; 2006 Oct; 66(19):9461-6. PubMed ID: 17018601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
